Bridgeway Capital Management’s Serina Therapeutics SER Stock Holding History

Bridgeway Capital Management’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,116	Closed	-$55.7K	–	1382
2023 Q4	$55.7K	Hold	4,116	–	–	﹤0.01%	1304
2023 Q3	$98.4K	Hold	4,116	–	–	﹤0.01%	1234
2023 Q2	$129K	Sell	4,116 -711	-15%	-$15.2K	﹤0.01%	1215
2023 Q1	$113K	Hold	4,827	–	–	﹤0.01%	1214
2022 Q4	$93.7K	Hold	4,827	–	–	﹤0.01%	1228
2022 Q3	$95K	Hold	4,827	–	–	﹤0.01%	1282
2022 Q2	$98K	Hold	4,827	–	–	﹤0.01%	1228
2022 Q1	$145K	Hold	4,827	–	–	﹤0.01%	1222
2021 Q4	$185K	Hold	4,827	–	–	﹤0.01%	1171
2021 Q3	$160K	Sell	4,827 -2,133	-31%	-$89.5K	﹤0.01%	1221
2021 Q2	$379K	Sell	6,960 -1,706	-20%	-$85.6K	0.01%	1147
2021 Q1	$494K	Buy	8,666 +2,844	+49%	+$199K	0.01%	1087
2020 Q4	$311K	Hold	5,822	–	–	0.01%	1112
2020 Q3	$166K	Buy	5,822 +1,421	+32%	+$50.7K	﹤0.01%	1197
2020 Q2	$147K	Buy	+4,401	New	+$130K	﹤0.01%	1194
2020 Q1	–	Sell	-684	Closed	-$44K	–	1366
2019 Q4	$44K	Hold	684	–	–	﹤0.01%	1281
2019 Q3	$47K	Hold	684	–	–	﹤0.01%	1276
2019 Q2	$88K	Hold	684	–	–	﹤0.01%	1253
2019 Q1	$97K	Hold	684	–	–	﹤0.01%	1281
2018 Q4	$72K	Buy	+684	New	+$87K	﹤0.01%	1326

Other funds holding SER

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RAM

Riggs Asset Management Dallas, Pennsylvania $486M AUM 59.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AFG

Albion Financial Group Salt Lake City, Utah $1.55B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bridgeway Capital Management's SER Position: Q1 2024 in Review

Bridgeway Capital Management sold out of Serina Therapeutics (SER) in Q1 2024, closing a stake of 4,116 shares — an estimated $55.7K sold.

Bridgeway Capital Management first reported a position in SER in Q4 2018 and held it in 20 quarters. The position peaked at $494K in Q1 2021. 13 funds tracked by Wall St. Rank hold SER as of Q1 2024.

Bridgeway Capital Management reported no remaining Serina Therapeutics position as of Q1 2024 after selling out during the quarter.
Bridgeway Capital Management sold 4,116 Serina Therapeutics shares in Q1 2024, an estimated $55.7K.
Bridgeway Capital Management first reported a position in Serina Therapeutics in Q4 2018 and held it in 20 quarters.
Bridgeway Capital Management's Serina Therapeutics position peaked at $494K in Q1 2021.
13 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2024.

Based on Bridgeway Capital Management's 13F filing for Q1 2024, filed 15 May 2024.